IL10 and COVID-19: Studies have found that IL-10 increases ACE2 mRNA expression in lung-derived Calu-3 cells and human umbilical vein endothelial cells (HUVEC), thereby providing cardiopulmonary protection in COVID-19 using a negative feedback mechanism that inhibits inflammation.